Literature DB >> 18014409

Typhoid Carriers -A Study of Their Disease Producing Potentialities Over a Series of Years as Indicated by a Study of Cases.

G W Anderson, A D Hamblen, H M Smith.   

Abstract

Year:  1936        PMID: 18014409      PMCID: PMC1562732          DOI: 10.2105/ajph.26.4.396

Source DB:  PubMed          Journal:  Am J Public Health Nations Health        ISSN: 0002-9572


× No keyword cloud information.
  1 in total

1.  THE PREVALENCE OF CARRIERS AMONG RECOVERED TYPHOID PATIENTS.

Authors:  C N Leach; S A Dehler; L C Havens
Journal:  Am J Public Health (N Y)       Date:  1926-04
  1 in total
  7 in total

1.  Efficacy of chloramphenicol therapy for typhoid carriers.

Authors:  M E O'CONNOR
Journal:  Public Health Rep       Date:  1958-11       Impact factor: 2.792

2.  Sanitary ventilation.

Authors:  W F WELLS
Journal:  Am J Public Health Nations Health       Date:  1948-06

3.  Age and Sex as Factors in the Development of the Typhoid Carrier State, and a Method for Estimating Carrier Prevalence.

Authors:  W R Ames; M Robins
Journal:  Am J Public Health Nations Health       Date:  1943-03

4.  Carrier-Borne Typhoid Fever in New York State: With Special Reference to Attack Rates Among Household Contacts.

Authors:  E L Stebbins; E Reed
Journal:  Am J Public Health Nations Health       Date:  1937-03

5.  Development of a murine model of chronic Salmonella infection.

Authors:  S Sukupolvi; A Edelstein; M Rhen; S J Normark; J D Pfeifer
Journal:  Infect Immun       Date:  1997-02       Impact factor: 3.441

Review 6.  Live Attenuated Human Salmonella Vaccine Candidates: Tracking the Pathogen in Natural Infection and Stimulation of Host Immunity.

Authors:  James E Galen; Amanda D Buskirk; Sharon M Tennant; Marcela F Pasetti
Journal:  EcoSal Plus       Date:  2016-11

7.  Salmonella typhimurium persists within macrophages in the mesenteric lymph nodes of chronically infected Nramp1+/+ mice and can be reactivated by IFNgamma neutralization.

Authors:  Denise M Monack; Donna M Bouley; Stanley Falkow
Journal:  J Exp Med       Date:  2004-01-19       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.